Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.23.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities:    
Net earnings (loss) $ 164 $ (2,502)
Adjustments to reconcile net earnings (loss) to net cash provided by operating activities:    
Depreciation and amortization 309 371
Impairment of intangible assets   3,081
Stock-based compensation 40 46
Realized and unrealized (gains) losses on financial instruments, net 95 (29)
(Gains) losses on sale leaseback transactions (119) (520)
Gain on insurance proceeds, net of fire related costs (225) (139)
Insurance proceeds received for operating expenses and business interruption losses 226 96
Loss on disposition of Zulily, net 64  
(Gain) loss on extinguishment of debt (45) (8)
Deferred income tax expense (benefit) 62 45
Other, net 13 (59)
Changes in operating assets and liabilities    
Decrease (increase) in accounts receivable 378 483
Decrease (increase) in inventory 63 (163)
Decrease (increase) in prepaid expenses and other assets 90 98
(Decrease) increase in trade accounts payable (103) (418)
(Decrease) increase in accrued and other liabilities (410) (419)
Net cash provided (used) by operating activities 602 (37)
Cash flows from investing activities:    
Capital expenditures (151) (171)
Expenditures for television distribution rights (111) (36)
Cash proceeds from dispositions of investments 71 12
Cash paid for disposal of Zulily (35)  
Proceeds from sale of fixed assets 202 701
Insurance proceeds received for fixed asset loss 54 184
Payments for settlements of financial instruments (179)  
Proceeds from settlements of financial instruments 167  
Other investing activities, net   14
Net cash provided (used) by investing activities 18 704
Cash flows from financing activities:    
Borrowings of debt 1,137 2,069
Repayments of debt (1,893) (2,577)
Dividends paid to noncontrolling interest (35) (39)
Dividends paid to common shareholders (8) (11)
Indemnification agreement settlement 26  
Other financing activities, net (3) (13)
Net cash provided (used) by financing activities (776) (571)
Effect of foreign currency exchange rates on cash, cash equivalents and restricted cash (17) (59)
Net increase (decrease) in cash, cash equivalents and restricted cash (173) 37
Cash, cash equivalents and restricted cash at beginning of period 1,285 596
Cash, cash equivalents and restricted cash at end of period $ 1,112 $ 633